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Biofilma b s t r a c t
The application of mesoporous bioactive glasses (MBGs) containing controllable amount of different ions,
with the aim to impart antibacterial activity, as well as stimulation of osteogenesis and angiogenesis, is
attracting an increasing interest.
In this contribution, in order to endow nano-sized MBG with additional biological functions, the frame-
work of a binary SiO2-CaO mesoporous glass was modified with different concentrations of copper ions (2
and 5% mol.), through a one-pot ultrasound-assisted sol-gel procedure. The Cu-containing MBG (2% mol.)
showed high exposed surface area (550 m2 g1), uniform mesoporous channels (2.6 nm), remarkable
in vitro bioactive behaviour and sustained release of Cu2+ ions.
Cu-MBG nanoparticles and their ionic dissolution extracts exhibited antibacterial effect against three
different bacteria strains, E. coli, S. aureus, S. epidermidis, and the ability to inhibit and disperse the biofilm
produced by S. epidermidis.
The obtained results suggest that the developed material, which combines in single multifunctional
agent excellent bioactivity and antimicrobial ability, offers promising opportunities for the prevention
of infectious diseases and the effective treatment of bone defects.
Statement of Significance
In order to endow mesoporous bioactive glass, characterized by excellent bioactive properties, with addi-
tional biological functions, Cu-doped mesoporous SiO2-CaO glass (Cu-MBG) in the form of nanoparticles
was prepared by an ultra-sound assisted one pot synthesis.
Statement of Significance: The analysis of the bacterial viability, using different bacterial strains, and
the morphological observation of the biofilm produced by the Staphylococcus epidermidis, revealed the
antimicrobial effectiveness of the Cu-MBG and the relative ionic extracts against both the bacterial
growth and the biofilm formation/dispersion, providing a true alternative to traditional antibiotic sys-
temic therapies.
Statement of Significance: The proposed multifunctional agent represents a promising and versatile
platform for bone and soft tissues regeneration.
 2017 Acta Materialia Inc. Published by Elsevier Ltd. This is an open access article under the CCBY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Bone tissue shows an intrinsic potential of self-healing in
response to injury [1]. However, the effective treatment of bone
defects, especially the larger one resulting from impaired bone
regeneration, compromised regenerative process such as
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represents a challenging clinical issue [2]. To this aim, in the last
decades, a wide class of bioactive materials have been proposed
as bone-tissue regeneration systems [3,4].
Recently, one of the most appealing approach to design novel
biomaterials for bone repair is to combine in a single multifunc-
tional component several abilities, including osteoconductivity
(for guidance of new bone growth) and the capacity to stimulate
both osteogenesis (for promoting new bone formation) and angio-
genesis (for inducing vascularization) [5–7]. Furthermore, bone
healing is also substantially hindered when infection occurs,
mainly after an open fracture. Conventional treatments include
systemic antibiotic administration, surgical debridement or wound
drainage [8]. These actions, however, are often ineffective and may
result in quite serious complications leading to extra surgeries,
with a consequent high burden in terms of pain and social costs.
Consequently, the development of bioactive materials enabled
with antibacterial properties would represent a valuable solution
in preventing post-surgical infections.
In the field of advanced bioceramics, mesoporous bioactive
glasses (MBGs), which combine the textural parameters of ordered
mesoporous matrices with the properties of conventional bioactive
sol-gel glasses, have received increasing attention as bone-tissue
regeneration systems [8–14]. The unique textural properties of
these templated-glasses, synthesized mostly in the systems SiO2-
CaO or SiO2-CaO-P2O5, lead to significantly enhanced bioactivity
compared with conventional bioactive glasses, making them ideal
components for bone regeneration. More recently, the application
field of MBGs has moved a big step forward by including control-
lable amount of different ions in their composition. In particular,
the final aim is to impart other biological functions, including
anti-bacterial activity, as well as stimulation of osteogenesis and
angiogenesis, by means of the incorporation of metallic elements
with therapeutical effect [15,16]. Furthermore, the large exposed
surface area and the accessible pore volume shown by MBGs pro-
vide excellent drug delivery ability, which synergistically com-
bined with the release of therapeutic ions, can be exploited for
the development of multifunctional biomaterials. In the past five
year, different therapeutic ions, including Ag+, Sr2+, Cu2+ and Co2+
have been incorporated into MBG-based scaffolds and their release
had been related to the enhancement of several biological func-
tions [17–21]. In particular, the release of Sr2+ ions from Sr-
containing MBG scaffolds was found to significantly stimulate
new bone formation in osteoporotic bone defects in vivo [22] and
MBG scaffolds incorporating Co2+ and Cu2+ ions have been reported
to promote angiogenesis in vitro and in vivo [23].
Some recent studies have focussed on the development of MBG
particles characterized by size ranging from ten to hundreds of
nanometres and by excellent surface bioreactivity [24]. This class
of nanostructured materials is extremely attractive in relation to
regenerative medicine, as it allows to widen the use of MBGs,
including the design of nanocomposite with biopolymers, the dis-
persion as active phase in injectable gels or the production of func-
tional coatings on different materials (porous ceramics, metals) to
combine improved mechanical properties and high bioactivity
[25–28]. El-Fiqi et al. [29] have recently attained, through an
ultrasound-assisted sol-gel process, the preparation of MBG
nanoparticles with binary SiO2-CaO composition, and had shown
their capacity to act as delivery nanovehicles of therapeutic mole-
cules, along with excellent apatite forming ability and good cell
viability.
In this work, with the aim to endow nano-sized MBGs with
additional biological functions, the framework of a binary SiO2-
CaO system was modified with different amount of copper ions,
due the recognized therapeutic properties of this element. Indeed,
the sustained release of Cu2+ ions, as hypoxia-mimicking ion, isknown to enhance bone density by inhibiting active bone resorp-
tion [30,31]. Furthermore, very recently, a systematic evaluation
of copper-doped mesoporous silica nanospheres, through in vitro
biological assessment under immune environment, have finely evi-
denced that these nanomaterials can induce osteogenic/angiogenic
factors and suppress osteoclastogenic factors by immune cells, evi-
dencing their potential as immunomodulatory agent for tissue
regeneration/therapy applications [32]. Copper is also recognized
to be an antimicrobial agent [17], a crucial aspect for an effective
bone repair process.
In this contribution, the insertion of Cu ions within the frame-
work of a mesoporous SiO2-CaO bioglass was carried out through
a one-pot ultrasound-assisted sol-gel procedure. The effect of cop-
per insertion on the textural features and the in vitro bioactive
response of the resulting systems were assessed, along with the
Cu2+ release profiles. The antibacterial properties of the synthe-
sized copper containing MBG and their ionic extracts were tested
using different bacterial strains. Furthermore, the ability in inhibit-
ing and dispersing the biofilm produced by the Staphylococcus epi-
dermidis was investigated.2. Materials and methods
2.1. Preparation of Cu-containing MBGs
Copper-loaded MBGs were synthesized through an ultra-sound
assisted base catalysed sol-gel method, by incorporating Cu into
the MBG framework to replace part of calcium (Ca). MBG with
2% molar percentage of Cu (molar ratio Cu/Ca/Si = 2/13/85, named:
Cu_MBG 2%) and 5% molar percentage of Cu (molar ratio Cu/Ca/
Si = 5/10/85, named: Cu_MBG 5%) were prepared by the same
method. Briefly, 5 g of cetyltrimethylammonium bromide (CTAB,
98%, Sigma) was completely dissolved by stirring in 120 mL of
absolute methanol, whose pH was adjusted to 12.5 by adding
about 30 mL NH4OH. Into this solution, proper amounts of calcium
nitrate tetrahydrate (Ca(NO3)24H2O, 99%) and copper chloride
(CuCl2, 99%) were dissolved. In a separate batch, 0.895 g tetraethyl
orthosilicate (TEOS, 99%) were dissolved in 30 mL absolute metha-
nol and was then added to the first solution with the simultaneous
application of ultra-sound using a SONOPULS Ultrasonic Homoge-
nizers HD 3200. The output power was 150 W in a 10 s on/10 s off
cycle for 20 min. This solution was stirred at room temperature for
24 h. Then the precipitate was separated by centrifugation at
5000 rpm for 5 min, washed one time with distilled water and
two times with absolute ethanol. The final precipitate was dried
at 70 C for 12 h and calcined at 600 C in air for 5 h at a heating
rate of 1 C min1 using a Carbolite 1300 CWF 15/5. A sample with-
out Cu (molar ratio Si/Ca = 85/15, named MBG) was also prepared
by the same method and used as reference system.2.2. Materials characterization
The morphology of the synthesized nanoparticles was analysed
by Field-Emission Scanning Electron Microscopy (FE-SEM) micro-
scopy using a Philips 525M instrument. Compositional analysis of
the powders was performed by energy dispersive spectroscopy
(EDS; Philips Edax 9100).
The samples were characterized by X-ray diffraction (XRD)
through a Philips X’pert diffractometer (Cu Ka radiation) and nitro-
gen adsorption measurements at 77 K performed using a Quan-
tachrome Autosorb 1. Samples were outgassed at 423 K for 5 h
before analysis. BET specific surface areas have been calculated in
the relative pressure range 0.04–0.1 and the pore size has been
evaluated through the DFT (Density Functional Theory) method,
using the NLDFT equilibrium model for cylindrical pore.
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imaging and local EDS spectroscopy was performed on a JEOL
JEM300FEG electron microscope equipped with an ISIS 300 X-ray
microanalysis system (Oxford Instruments). Cu_MBG 2% and
Cu_MBG 5% samples were ultrasonically dispersed in n-butanol
and transferred to carbon coated nickel grids to analyze the copper
distribution in the nanospheres.
A PHI 5000 Versaprobe II Scanning X-ray Photoelectron
Spectrometer (XPS), equipped with a monochromatic Al K-alpha
X-ray source (1486.6 eV energy, 15 kV voltage and 1 mA anode
current), was used to investigate the surface chemical composition.
A spot size of 100 mm was used in order to collect the photoelec-
tron signal for both the high resolution (HR) and the survey
spectra. Different pass energy values were exploited: 187.85 eV
for survey spectra and 23.5 eV for HR peaks. The core level spectra
were deconvoluted with a nonlinear iterative least squares
Gaussian fitting procedure.
2.3. Evaluation of Cu ion release
In order to evaluate Cu ion release, 30 mg of copper-containing
samples were placed in a plastic container with 30 mL of SBF (final
concentration of 1 mg/mL of SBF) prepared according to Kokubo
recipe [33]. The samples were kept immersed for different times
up to 7 days at 37 C in an orbital shaker IKA KS 4000 with an agi-
tation rate of 150 rpm. At each time point, the suspension was cen-
trifuged and 1 mL of the supernatant solution was collected and
analysed by inductively coupled plasma atomic emission spec-
trometry technique (ICP-AES) through the ICPMS Thermoscientific
ICAPQ spectrometer.
2.4. Bioactivity assessment
In vitro bioactivity was assessed by using the methodology
described in ref [34], where a unified method for the evaluation
of HA-forming ability of bioactive glasses in powder form is pro-
posed. In particular, 30 mg of powders MBG and Cu_MBG 2% were
soaked in 30 mL of SBF for 3 h, 1, 3, 7 and 14 days. The bottles were
placed inside an orbital shaker IKA KS 4000 at a fixed temperature
of 37 C. At each selected time point, the powders were removed
by centrifugation at 5000 rpm for 5 min, rinsed with bi-distilled
water and dried in oven at 70 C for 12 h. The pH of SBF was mea-
sured at each time point. The powders were analysed by FESEM
and by XRD to detect the HA phase formation.
2.5. Antibacterial property of nanoparticles
2.5.1. Bacterial strains and culture conditions
The microorganisms used in this study were Escherichia coli RB
(E. coli RB), Staphylococcus aureus 8325-4 (S. aureus 8325-4) and
Staphylococcus epidermidis (S. epidermis RP62A), being the later a
strong biofilm-producing strain [35,36]. E. coli RB was provided
by the ‘‘Zooprofilattico Institute of Pavia” (Italy) whereas S. aureus
8325-4 and S. epidermidis RP62-A were kindly supplied by Timothy
J. Foster (Department of Microbiology, Dublin, Ireland). All bacteria
strains were routinely grown in their culture medium overnight
under aerobic conditions at 37 C using a shaker incubator (New
Brunswick Scientific Co., Edison, NJ, USA): E. coli RB in Luria Bertani
Broth (LB) (Difco, Detroit, MI, USA), S. aureus 8325-4 in Brian Heart
Infusion (BHI) (Difco) and S. epidermidis RP62A in tryptic soy broth
(TSB, Difco). These cultures were statically incubated at 37 C
under aerobic conditions and reduced to a final density of
1  1010 cells/mL as determined by comparing the optical density
(OD600) of the sample with a standard curve relating OD600 to cell
number.Two different experimental conditions were used to evaluate
the antibacterial activity of un-doped and doped nanoparticles.
For the first experimental condition, MBG or Cu_MBG 2% suspen-
sions in sterile phosphate-buffered saline, (PBS: 137 mM NaCl,
2.7 mM KCl, 4.3 mM Na2HPO4, pH 7.4) with a final concentration
of 2 mg/mL were prepared, sonicated (ultrasonic bath, FALC Instru-
ments, Italy) for 5 min at room temperature, and properly diluted
to obtain concentrations of 31, 63, 125, 250, 500, 1000 and
2000 mg/mL. The obtained suspensions were further sonicated for
5 min at room temperature prior to the direct incubation with bac-
terial cells.
The second experimental condition was analogously per-
formed, but in order to evaluate the antibacterial proprieties
ascribable to the released Cu2+ ions from Cu_MBG 2%, un-doped
and doped MBGs were dispersed in sterile PBS (2 mg/mL) and kept
soaked for 3 h and 24 h, then centrifuged and the supernatants
collected for antibacterial activity tests. Bacterial strains were
incubated without (control) or with increasing serial dilutions of
the extracts collected after 3 h and 24 h from the MBG and
Cu_MBG 2% suspensions, respectively. The control samples of both
the experimental conditions were performed by addition of the
same volume of PBS. Each experiment condition was repeated
three times.2.5.2. Evaluation of antibacterial effect on bacterial planktonic growth
For both experimental conditions, a predefined number (10^4/
mL) of Gram negative (E. coli RB) and Gram positive (S. aureus
8325-4 and S. epidermidis RP62A) cells were incubated in their
culture broth at 37 C in 96-well microtiter plates. For the first
experimental condition, bacterial cells were untreated (control)
or treated with nanoparticle suspensions at increasing concen-
trations, ranging from 31 up to 2000 mg/mL, for 1 and 3 days,
respectively. For the second experimental condition, bacterial
cells were untreated (control) or treated with increasing serial
dilutions of extracts previously collected at 3 and 24 h from of
MBG or Cu_MBG 2% suspensions (2 mg/mL) and incubated for
1 day.
For both experimental conditions, at fixed incubation times, the
quantitative 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium
bromide (MTT Sigma Aldrich, St Louis, MO, USA) assay was per-
formed to assess the dehydrogenase activity, as an indicator of
the metabolic state of cells, as previously described [37]. The bac-
terial viability was expressed as percentage related to the control
set equal to 100%.2.5.3. Evaluation of antibacterial effect on S. epidermidis biofilms
For biofilm experiments, overnight culture of S. epidermidis
RP62A was diluted in its broth culture medium with the addition
of 0.25% glucose [38]. Aliquots (100 lL) of the diluted bacterial sus-
pensions were inoculated into 96-well flat-bottom sterile polystyr-
ene microplates (Costar, Corning, NY, USA) as follows: i. without
(control) or with a suspension of 2 mg/mL of MBG or Cu_MBG 2%
nanoparticles in PBS; ii.without (control) or with extracts collected
after 24 h of incubation with MBG or Cu_MBG 2% suspension
(2 mg/mL) in PBS. In both cases (i and ii) the experiments were per-
formed in two different types of settings: a. nanoparticles suspen-
sions or nanoparticles extracts were contemporarily incubated
with biofilm growing cultures in order to evaluate their effects dur-
ing biofilm formation; b. nanoparticles suspensions or nanoparti-
cles extracts were added after the biofilm formation, to assess
their effects on the formed biofilms. After fixed incubation times,
biofilms were washed twice with PBS to remove planktonic cells
and loosely adhering bacteria [39]. Viability quantification of
microbial cells inhabiting the biofilms was performed by MTT test
as described above.
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For morphological evaluation, biofilm untreated (control) or
treated with nanoparticles suspensions or their extracts for both
the experimental settings (as described above) were grown in plas-
tic cell culture coverslip disks (Thermanox Plastic, Nalge Nunc
International, Rochester, New York) seeded on the bottom of a
24-well culture plates and incubated for 24 h at 37 C. Briefly,
the disks were washed several times and then fixed for SEM with
2.5% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.2 for 1 h at
4 C. After additional washes, they were incubated with increasing
concentrations of ethanol (25%, 50%, 75% and 96%) for 10 min each,
dried to the critical point using an Emitech K-850 apparatus (Emi-
tech, Ashford, Kent, UK) and placed on a mounting base [38].
Finally, the disks were coated with gold layer and examined
through SEM analysis (Zeiss EVO-MA10 scanning electron micro-
scope, Carl Zeiss, Oberkochen, Germany).2.5.5. Statistical analysis
All statistical calculation was carried out using GraphPad Prism
5.0 (GraphPad Inc., San Diego, CA). Statistical analysis was per-
formed using Student’s unpaired t-test and through one-way vari-
ance analysis (ANOVA), followed by Bonferroni post hoc, for
multiple comparisons (significance level of p  0.05).3. Results
3.1. The morphological and structural characterization of Cu_MBGs
The morphology of mesoporous glass nanoparticles doped with
defined concentrations of copper ions, was observed by high reso-
lution FE-SEM. The images of Cu_MBG 2% (Fig. 1A) revealed parti-
cles with a uniform spheroidal morphology, with size ranging
between 170 and 200 nm. Energy-dispersive spectrometry analysis
(EDS) confirmed the incorporation of Cu inside the framework: the
detected Cu/Si molar ratio, as average of three measurements,
resulted in fair agreement with the nominal ratio (Fig. 1B).
TEM observations showed that the nanoparticles contain meso-
pores throughout their inner structure, in the form of a worm-like
system (Fig. 1C). Quantitative analysis using EDS mapping, coupled
to TEM, was used to explore the element distribution in the sample
and showed that Cu ions, like the other elements, were evenly dis-
tributed within the whole of the particle (Fig. 1D).
FE-SEM observation of Cu_MBG 5% sample (Fig. 1E) showed
spheroidal particles whose size ranges between 180 and 230 nm,
on average slightly larger than what was observed for Cu_MBG
2%. EDS analysis reported in the inset of Fig. 1E showed the incor-
poration of copper with a molar concentration very close to the
nominal ratio. TEM images of Cu_MBG 5%, (Fig. 1F) allowed dis-
cerning a core-shell morphology for this sample, with a shell char-
acterized by a regular mesoporous structure and an internal core
characterized by larger and irregular cavities. In this case, EDS
mapping analysis evidenced different Si, Ca and Cu atomic percent-
ages in the core and shell regions of the particles, showing, a higher
concentration of Ca and Cu ions in the core (Ca/Si = 0.13 and Cu/
Si = 0.15) compared to the outer shell (Ca/Si = 0.05 and Cu/
Si = 0.06).
The mesoporous structure of Cu-modified MBGs systems was
confirmed by the N2 adsorption-desorption isotherms (Fig. 2),
which revealed that the isotherm curves of MBG, Cu_MBG 2%
and Cu_MBG 5% had type-IV isotherm with a well-defined step
at relative pressure (P/P0) below 0.3, indicative of the filling of uni-
form mesopores. The capillary condensation observed at higher
relative pressures for Cu_MBG 5% (green curve) is ascribable to
intra-particles voids or to the disordered porosity located in the
particle core, discernible from TEM images.The values of BET specific surface area, mesopores volume and
pore diameter for the investigated samples are reported in Table 1:
a decrease of surface area and pore volume was found with
increasing the amount of copper ion. The mesopore diameter was
approximately 2.6 nm in the Cu-containing samples, which is that
typical of CTAB-templated systems.
In the high-angle XRD patterns (Supplementary information,
SI.1), the broad peak at 23 corresponded to amorphous silica,
and no diffraction peaks of copper oxide (CuOx) were observed in
these samples, indicating that the incorporated copper does not
form oxide crystals.
In order to investigate the nature of the copper species incorpo-
rated inside the glass framework, XPS spectra were recorded on
Cu_MBG 2% and Cu_MBG 5%. Fig. 3 shows the deconvoluted XPS
spectra of Cu_MBG 2% and Cu_MBG 5% in the Cu2p3/2 region.
The components at 935.7 eV and 933.3 eV obtained through the
deconvolution and their integrated peaks areas are reported in
Table 2: an evident difference in the relative amount of the two
components was found.
3.2. Copper ion release from nanoparticles in SBF
The ionic concentrations (mg/mL) of Cu2+ species in SBF medium
after contact for 7 days with Cu-containing powders are reported
in Fig. 4.
In the case of Cu_MBG 2%, a sustained release of Cu2+ is
observed over the 7 days of soaking and the percentage released
resulted approximately 90%. Furthermore, the EDS analysis of the
sample after the release tests did not reveal the presence of resid-
ual copper, suggesting a quantitative release of the functional ion.
At variance, the release test carried out with Cu_MBG 5% evidenced
a very low percentage of released Cu2+ (around 10%), suggesting
that copper ions are mostly inaccessible.
3.3. Bioactive behaviour of Cu_MGB 2%
Based on the obtained release kinetics for Cu2+ species, the
investigation about the bioactive properties was uniquely per-
formed on Cu_MBG 2% and on MBG for comparison.
Both samples showed a remarkable bioactivity when soaked in
SBF. The precipitation of hydroxyapatite (HA) was assessed after
only 3 h of immersion and a conspicuous amount of it could be
easily detected after 24 h of soaking.
Fig. 5 shows FE-SEM images of Cu_MBG 2% nanoparticles after 3
(Fig. 5A) and 7 days (Fig. 5B) and related EDS spectra (Fig. 5D0 and
D00) of SBF soaking: globe-shaped agglomerates are easily distin-
guishable on the nanoparticles surface. The phase nucleated after
3 h of soaking, as assessed by EDS analysis, can be identified as
Ca-deficient HA (Ca/P = 1.51). The Ca content in the newly formed
phase gradually rises as soaking time increases and after seven
days, a molar Ca/P ratio of 1.62 was detected, which is in the range
of calcium-deficient biological apatite. The pH of SBF remained in
the physiological range during particles soaking (between 7.4
and 7.5).
The WAXRD spectrum of the Cu_MBG 2% sample after 24 h of
soaking in SBF is reported in Fig. 5C. Marked peaks at 32 and
26 and other less intense reflections at about 40, 47 and 49
were assigned to the (002), (211), (300), and (213) reflections
of HA (reference code 01-074-0565). The other narrow peaks are
ascribable to calcite (reference code 01-083-1762).
3.4. Antibacterial property of MBG nanoparticles and their extracts on
bacterial planktonic growth
In the present study, the synthesized nanoparticles (first exper-
imental condition) and their extracts (second experimental
Fig. 1. SEM image of Cu_MBG 2% (A), EDS spectrum (B), TEM image (C) and EDS mapping analysis of Cu_MBG 2% (D), Si (red), O (blue), Cu (green) and Ca (yellow) are
uniformly distributed in the nanoparticles; SEM image of Cu_MBG 5% (E), related EDS spectrum (inset), TEM image (F). (For interpretation of the references to colour in this
figure legend, the reader is referred to the web version of this article.)
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human pathogenic bacteria, namely, E. coli RB, S. aureus 8325-4
and S. epidermidis RP62A (Figs. 6 and 7). For the first condition
(Fig. 6), all the bacteria strains were incubated with different con-
centrations of both MBG and Cu_MBG 2% particles for 1 and 3 days
of culture, respectively. The results in Fig. 6 evidenced a similar
trend on all bacteria cultures after the incubation with the Cu_MBG
2% nanoparticles, showing that the bacterial growth suppression
was clearly correlated to the presence of copper and its increasing
availability for higher concentration. After 1 day of incubation with
a concentration above 250 mg/mL, approximately 30–40% of
growth inhibition was observed for all types of bacteria, in compar-
ison to the control (cultures without nanoparticles). In particular,
the obtained results showed that at longer incubation times(3 days) with the higher suspension concentration (2 mg/mL), the
reduction of viability for both E. coli RB and S. aureus 8325-4 cul-
tures was 70–75%, and for S. epidermidis around 50%.
Compared to MBG cultures both at short and long incubation
times, E. coli RB and S. aureus showed a slightly lower cell viability
using 2 mg/mL or 500 mg/mL of Cu_MBG 2%, respectively. At vari-
ance, with S. epidermidis, the difference in cell viability was dose-
dependent, starting from the lower concentrations and becoming
more evident at the higher doses (Fig. 6). Interestingly, the results
showed that MBG, although not containing copper, exhibited a
slight antibacterial effect against the E. coli RB and S. aureus
(around 25%) remaining persistent at all the tested concentrations
(not dose-dependent). On the contrary, with S. epidermidis cultures,
the obtained results highlighted a clear effect related to copper,
Fig. 3. The XPS deconvoluted spectra in the Cu2p3/2
Fig. 2. N2 adsorption-desorption isotherms of MBG (blue), Cu_MBG 2% (red) and
Cu_MBG 5% (green) show type IV curve with H1 hysteresis, indicative of a
mesoporous structure. (For interpretation of the references to colour in this figure
legend, the reader is referred to the web version of this article.)
Table 1
Structural features of MBG, Cu_MBG 2% and Cu_MBG 5% samples.
Samples Specific Surface
(m2 g1)
Pore Volume
(cm3 g1)
DFT Pore Size
(nm)
MBG 621 1.05 2.9
Cu_MBG 2% 550 0.26 2.6
Cu_MBG 5% 224 0.11 2.6
Table 2
Deconvoluted contributions of Cu2p core level and relative percentages.
Peak position (eV) Peak ar
Cu_MBG 2% 933.3 80.3
Cu_MBG 5% 933.3 48.5
498 A. Bari et al. / Acta Biomaterialia 55 (2017) 493–504suggesting a different sensitivity of bacteria to the MBG composi-
tion and most likely a different antibacterial mechanism of action
(Fig. 6).
In order to evaluate the influence of the released copper on the
antibacterial effect, the same experiments were performed in par-
allel with both MBG and Cu_MBG 2% extracts (Fig. 7). Overall, it
was clear that there was a positive correlation between the
extracts concentrations and bacteria growth inhibition, showing
the same trend observed in the experiments based on the direct
contact with nanoparticles. Interestingly, in all bacteria cultures,
a cell viability reduction was observed in the samples treated with
extract of Cu_MBG 2% collected after 24 h (Fig. 7B), if compared
with extracts from MBG, hence confirming the role of copper in
the observed antibacterial activity. The same experiments carried
out with extracts of Cu_MBG 2% and MBG collected after 3 h
revealed a rather varying trend in the bacterial viability for all
the tested strains, which did not allow a reliable interpretation of
the data obtained for such short incubation times (Fig. 7A).3.5. Antibacterial effect of nanoparticles and their extracts on S.
epidermidis biofilm
S. epidermidis RP62A is known to produce considerable quanti-
ties of polysaccharide intercellular adhesions, inducing biofilm for-
mation [35,40]. To evaluate the antibacterial activity on
staphylococcal biofilms, S. epidermidis cultures were incubated
with MBG and Cu_MBG 2% suspensions (2 mg/mL) or with related
extracts collected after 24 h of incubation, either during the biofilm
formation or in the presence of pre-formed biofilms (Figs. 8 and 9).
A significant reduction of biofilm growth was determined when
the cultures were performed in the presence of Cu_MBG 2% parti-
cles if compared to MBG (Fig. 8A, indicated by ⁄⁄⁄) and untreated
cultures (data not shown). Moreover, a significant difference in cell
viability was obtained when a stable formed biofilm was treatedregion for Cu_MBG 2% (A) and Cu_MBG 5% (B).
ea% Peak position (eV) Peak area%
935.7 19.7
935.7 51.5
Fig. 4. Cu2+ release profiles of Cu_MBG 2% (blue) and Cu_MBG 5% (red) in SBF. (For
interpretation of the references to colour in this figure legend, the reader is referred
to the web version of this article.)
Fig. 5. SEM images of Cu_MBG 2% after 3 days (A) and 7 days (B) of soaking in SBF and X
asterisks are due to hydroxyapatite phase; EDX spectra of Cu_MBG 2% after 3 days (D0)
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Conversely, these effects were less marked in the presence of only
copper containing extracts (released by nanoparticles) when incu-
bated during the biofilms formation (Fig. 9A) or on the pre-formed
biofilms (Fig. 9C).
Furthermore, in order to visualize the biofilms morphology after
these treatments, SEM studies were carried out. As expected, large
cellular aggregates were observed in the biofilms produced by S.
epidermidis RP62A in all samples used as control (Figs. 8B and D;
9B and D). Conversely, the presence of nanoparticles during S. epi-
dermidis biofilm formation prevented and reduced the number of
adherent bacteria and cluster formation, more distinctly for
Cu_MBG 2% nanoparticles (Fig. 8B000). The addition of Cu_MBG 2%
suspension to an already formed staphylococcal biofilm, promoted
a visible dispersion of biofilm aggregates (Fig. 8D000) whereas the
contact with MBG suspension produced a less noticeable influence
on the biofilm morphology. Similar results were observed for bio-
film growing cultures (Fig. 9B000) or for formed biofilms (Fig. 9D000)
incubated with Cu_MBG 2% extracts, although the bacterial reduc-
tion was less evident in comparison to biofilms treated with
Cu_MBG 2% suspensions.
4. Discussion
In this study, a novel therapeutic Cu-doped mesoporous SiO2-
CaO glass was successfully obtained by a one-pot sol-gel synthesisRD pattern of Cu_MBG 2% after soaking in SBF for 7 days (C): the peaks marked with
and 7 days (D00) of soaking in SBF.
Fig. 6. Dose-dependence viability of different bacterial strains cultured with MBG and Cu_MBG 2% suspensions. Gram-negative (E. coli RB) and gram-positive (S. aureus 8325-
4 and S. epidermidis RP62A) bacterial strains were incubated with MBG or Cu_MBG 2% suspensions with concentrations in the range of 31–2000 lg/mL. After 1 and 3 days of
incubation, MTT assay was performed in all samples to evaluate cell viability expressed as percentage of viability determined in the absence of nanoparticles (set to 100%).
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method allowed us to obtain Cu-containing mesoporous spheroi-
dal particles with rather homogeneous size, very high exposed sur-
face area and uniform mesoporous channels. Two different
amounts of Cu2+ ion were incorporated inside the glass framework,
leading to systems characterized by evident changes in terms of
exposed surface area and release properties of Cu2+ ion. Specifi-
cally, the increase of copper amount in the synthesis had a negative
effect, affecting the formation of the mesostructure and leading to
a significant decrease of both exposed surface area and pore vol-
ume. These results confirm that the presence of an excess of metal
ions species in the reaction plays a negative role on the condensa-
tion of the silica precursors and the assembly of the mesophase
structure [32,41], leading to a significant decrease of the exposed
surface area in the obtained material.
TEM observations further confirmed that higher amount of dop-
ing cation had an evident impact on the structural properties of the
produced MBGs. Specifically, Cu_MBG 5%, at variance with
Cu_MBG 2%, shows particles characterized by a marked core-
shell morphology and, as highlighted by EDS mapping analysis,
by an enrichment of copper in the core compared to the outer shell.
The nature of incorporated copper species was analysed by XPS
analysis, which evidenced a sizeable difference in the relative con-
centration of detected Cu2+ species. A first component at lower
binding energy (933.3 eV) is consistent with values ascribed in
the literature to Cu2+ cations in extra-framework sites [42]. At vari-
ance, the component at higher binding energy, at ca 935.7 eV,
much higher than that for pure CuO (ca 933.8 eV) [43], is attributedto copper species with a strong electronic interaction with the lat-
tice, in analogy with results obtained for Cu-doped mesoporous sil-
icas [44]. Specifically, for the Cu_MBG 2% (Fig. 3A) sample most of
copper species are characterized by binding energy (933.3 eV) typ-
ical of extra-framework sites, with a limited contribution of species
at higher values, whereas the Cu_MBG 5% sample, as reported in
Fig. 3.B, shows a significant higher amount of Cu2+ at higher bind-
ing energy (935.7 eV). The chemical environment of the incorpo-
rated copper species plays an essential role in determining the
different release behaviour observed for the samples. The Cu_MBG
2% sample showed a sustained almost complete release of the
incorporated Cu2+, which supports the assignment proposed for
the component at 933.3 eV to species present as counter-ions of
the silica framework, located at the mesopore surface and thus
accessible for cation-exchange reactions when soaked in SBF. On
the other hand, the unexpected profile observed for Cu_MBG 5%,
characterized by a very limited release of Cu2+ species, could be
interpreted assuming the inaccessibility of mostly of the incorpo-
rated metal, as it is likely located in the particle cores or embedded
into the silica walls.
The Cu2+ release profile obtained for Cu_MBG 2% is in good
agreement with that reported for Cu-containing silica nanospheres
by Wu and co-workers [32], who investigated the effect of this
functional ion as osteoimmunomodulatory agent and as angiogen-
esis promoter, suggesting similar properties for copper when
released from MBG matrices.
The in vitro bioactive response of Cu_MBG 2%, in terms of
apatite-like forming ability, assessed through soaking in SBF, was
Fig. 7. Dose-dependence viability of different bacterial strains cultured with MBG and Cu_MBG 2% extracts. Gram-negative (E. coli RB) and gram-positive (S. aureus 8325-4
and S. epidermidis RP62A) bacterial strains were incubated without (control) or with increasing serial dilutions of the extracts collected after 3 (A) and 24 h (B) from 2 mg/mL
suspension of MBG or Cu_MBG 2% nanoparticles, respectively. After 1 day of incubation, MTT assay was performed in all samples to evaluate the viability expressed as
percentage of bacterial viability compared to control (set to 100%).
Fig. 8. Bacterial viability and morphology of biofilms treated with MBG and Cu_MBG 2% suspensions (2 mg/mL). Both MBG or Cu_MBG 2% suspensions were added to S.
epidermidis RP62A biofilm formation cultures (A) or after the formation of a stable staphylococcal biofilm (C). The biofilms cell viability was measured with the MTT assay
after 24 h of incubation in both experimental conditions. Results were expressed as percentage of the control (w/o nanoparticles). SEM representative images of the
staphylococcal biofilms formed in the absence (control) or in contact with both types of nanoparticles for 24 h are shown (B). SEM images of post formed biofilms, untreated
(control) or treated with both MBG or Cu_MBG 2% nanoparticles for 24 h, are also presented (D). Magnification, 2kx.
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Fig. 9. Bacterial viability and morphology of biofilms treated with extracts of MBG and Cu_MBG 2%. Undiluted supernatants collected at 24 h from 2 mg/mL of both types of
nanoparticle suspensions were added to S. epidermidis RP62A biofilm growing cultures (A) or after the formation of a stable staphylococcal biofilm (C). The biofilm viability
was measured with the MTT assay after 24 h of incubation. Results were expressed as percentage of the control. SEM images of staphylococcal biofilm formed without
(control) or with extracts for 24 h are shown (B). SEM images of post formed biofilms, incubated w/o (control) or with extracts for 24 h are also presented (D). Magnification,
2kx.
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typical peaks due to hydroxyapatite phase, the XRD pattern
revealed the components ascribed to calcite precipitate. The latter
is often found when bioactive glasses with a high content of cal-
cium (at least 30% mol of CaO) are soaked in SBF. These glasses,
when in contact with water-based solutions, release immediately
a high amount of Ca2+ ions, which, in the case of SBF, react with
the carbonate ions present, leading to calcite precipitation within
the very first hours of immersion [45–47]. Although the calcium
content for Cu_MBG 2% sample is not as high as reported in the lit-
erature, the very high exposed surface, due to the presence of the
mesopores, is expected to allow a high release of calcium ions in
terms of both the total amount and the kinetics. Calcite has been
reported to be resorbable [48] and osteoconductive, even without
the formation of a Ca-P-rich layer [49]. Therefore, the co-
precipitation of apatite and calcite can be considered as an index
of the mesoporous glass bioactivity [50].
As stated above, previous studies have documented the excel-
lent antibacterial function of soluble copper compounds against
many microorganisms [51,52]. In recent years, the interest in add-
ing metals (e.g. silver, copper, zinc), with proved antimicrobial
activity, to innovative nanoparticles and nanocomposites [53],
with the final aim to reduce or prevent a device-related infection,
and to reduce or inhibit bacterial colonization has grown. In the
present study, the antibacterial effect of Cu-doped mesoporous
bioglass nanoparticles against two gram-positive bacteria (S. aur-
eus and S. epidermidis) and one gram-negative (E. coli), was inves-
tigated. In agreement with the literature related to Cu-containing
nanocomposite systems [54], the results obtained in this work,
confirmed that the release of Cu2+ ions plays a fundamental role
on antimicrobial properties. The antibacterial effect and the mech-
anism of action of copper on bacteria viability is not fully eluci-
dated yet, however, it seems to be mainly associated to the
pleiotropic effects of copper on bacterial cells, through a multiple
mechanism of action. The results obtained in this work evidenced
that Cu-doped glass nanoparticles showed antimicrobial effect,
highly dependent to the dose and bacterial strains. The remarkable
difference might be attributed to the different properties ofbacteria surfaces [55]. In gram-positive bacteria, the absence of
an outer membrane and the presence of surface negatively charged
teichuronic and lipoteichoic acids within a single lipid bilayer sur-
rounded by a thick but porous layer of peptidoglycan (20–80 nm),
make them attractive to positively charges [56]. Therefore, the
inhibiting process is supposed to be most likely associated to the
action of released metal ions, which might be easily moved inside
the microbial cells or attached to the charged outer surfaces by
electrostatic attraction, resulting in cell apoptosis via protein
denaturation and disruption of cell membrane [57]. By contrast,
gram-negative bacteria expose a highly organized compact struc-
ture, which acts as a permeability barrier and prevents diffusion
to the inner plasma membrane for most high molecular weight
compounds, making them less attractive to metal nanoparticles
treatment. Moreover, the presence of copper tolerance mecha-
nisms in E. coli [58], including the activation transmembrane cop-
per export occurring from cytoplasm into the periplasmic space or
into the extracellular milieu and the copper sequestration by met-
allothioneins, can further explain the requirement of a higher
Cu_MBG concentrations to inhibit E. coli cultures in comparison
to the other bacterial strains.
At variance in E. coli and S. aureus bacteria, the Cu-doped MBG
antibacterial effect seems not to be merely due to the release of
metal ions in solution, but most likely the small size and the high
surface-to-volume ratio of Cu_MBG particles, account for the acti-
vation of cell death mechanisms [59,60]. In this regard, further
investigations are certainly required in order to fully elucidate
the mechanisms involved in the antimicrobial activity of the inves-
tigated systems.
Remarkably, this non-specific mode of action of copper-based
systems makes them powerful antimicrobial agents with an intrin-
sic low likelihood of inducing microbial resistance [61].
In recent years, the number of infections associated with
antibiotic-resistant bacteria has greatly increased. Many of these
infections are caused by microorganisms growing in biofilms, com-
plex bacterial communities surrounded by a self-producing extra-
cellular polymer matrix, able to resist both to antibiotic action and
to human immune system [62]. The formation of biofilm is a
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frequently colonise medical devices, causing persistent body-
related infections.
Unlike planktonic populations, bacterial cells embedded in bio-
films exhibit intrinsic resistance to antibiotics due to several speci-
fic defence mechanisms conferred by the biofilm environment,
including the inactivation of anti-microbial agents by exopolysac-
charide (EPS), over expression of stress-responsive genes, oxygen
gradients within the biofilm matrix and differentiation of a sub-
population of biofilm cells into resistant dormant cells [64,65].
The aforementioned features of biofilms place them amongst the
most serious problems currently faced by medicine and thus con-
siderable efforts are devoted to identify novel therapies to prevent
or treat biofilms. To this purpose, a potentially promising treat-
ment implies metal or metal oxide nanoparticles, showing anti-
bacterial and anti-biofilm activity [66–68].
In the present work, the obtained data showed that Cu_MBG 2%
nanoparticles, inhibited he bacterial growth and were also able to
counteract the formation of biofilm produced by S. epidermidis and
even to favour its dispersion.
The evidence of biofilm inhibition and dispersion was provided
both from the assessment of the bacterial viability and from the
morphological observations of biofilm through SEM analysis.
Cu_MBG 2% nanoparticles dramatically decreased the number of
viable cells within the tested biofilms and SEM results shows a sig-
nificant reduction of surface coverage by S. epidermidis biofilms.
Considering the widespread occurrence and significant impact
of S. epidermidis biofilms in a variety of clinical settings, the devel-
oped antimicrobial material offer promising opportunities for the
prevention of infectious diseases.
Consistent with other studies [17,61,69,70], these findings pro-
vide further proof of copper antimicrobial effectiveness against
both the bacterial growth and the biofilm formation and disper-
sion, offering a powerful alternative to traditional systemic thera-
pies based on antibiotics.
Antibiotic resistance is a major challenge in the treatment of
infectious diseases, particularly due to the emergence of
multidrug-resistant pathogenic strains (MDR). Thus, in perspec-
tive, the system proposed in the present study, due to the combi-
nation of excellent antibacterial and bioactive properties,
represents an effective agent, alone or in synergy with complemen-
tary approaches, for the treatment of bacterial diseases associated
to orthopaedic implant infections. The synergistic action of Cu-
doped MBGs nanoparticles, for instance in combination with vari-
ous antibiotics, could result in excellent inhibition of bacteria in
planktonic stage, reducing the therapeutic dose to treat the bacte-
rial infections and thereby reducing the toxicity risks. Moreover,
based on the observed anti-biofilm results, it could be envisaged
their application as antibacterial coatings of medical implants, to
make these devices more resistant to the bacterial colonization
and biofilm formation.5. Conclusions
In this study, a novel Cu-containing mesoporous bioactive glass
(Cu_MBG), in the form of spheroidal nanoparticles, was synthe-
sized via an efficient one-pot synthesis procedure. The incorpora-
tion of copper within the SiO2-CaO framework (up to 2% mol.)
led to a material characterized by very high specific surface area,
uniformmesopores, homogeneous distribution of copper, excellent
bioactive behaviour and the ability to release the copper ions at a
sustained rate in a biological buffer solution. The assessment of
the antibacterial properties of Cu_MBG nanoparticles and their
ionic extracts against E. coli, S. aureus and S. epidermidis showed a
very effective antibacterial ability against all the tested bacteriastrains, with a strain-dependent effect. A fundamental role on the
observed antibacterial activity was ascribed to copper ions
released by Cu_MBG particles, as highlighted by the reduction of
bacterial viability in the presence of their dissolution ionic extracts.
Furthermore, Cu_MBG 2% suspension, at proper concentration, is
able to reduce and disrupt the biofilm matrix.
Based on the these results, Cu_MBG shows a great potential as
multifunctional therapeutic agent for preventing diseases related
to infections and for stimulating bone regeneration.
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